In addition to these effects, SGLT2 inhibitors exhibit anticancer effects by modulating cancer cell metabolism, including inhibiting β-Catenin, activating AMPK and reducing ATP production, which suppresses DNA/RNA synthesis and proangiogenic factors [20]. Here, SLC5A2 is linked to cancer.